HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.

AbstractOBJECTIVE:
Familial Hypercholesterolemia (FH) is associated with an increased risk of cardiovascular disease (CVD). However, whether an individual heterozygous FH patient will develop CVD depends on other genetic- and environmental risk factors as well. LDL receptor-related protein with 11 ligand binding repeat (LR11) and its soluble form (sLR11) play a role in the progression of atherosclerosis. We investigated the involvement of LR11 and sLR11 in CVD development in FH patients and in LDLR deficient (Ldlr(-/-)) mice.
APPROACH AND RESULTS:
In statin-treated asymptomatic male heterozygous FH subjects, plasma sLR11 levels correlated with carotid intima-media thickness. Increased plasma sLR11 levels were found in Ldlr(-/-) and also in wild-type mice exclusively after high-fat feeding. Hepatic LR11 mRNA levels, however, were higher in chow-fed Ldlr(-/-) in comparison with wild-type mice and were further increased after a high fat diet. Similar results were obtained with Apoe(-/-) mice, but not with wild-type mice. LR11 mRNA and protein levels and release of sLR11 from cultured HepG2 and aortic smooth muscle cells were upregulated by postprandial triglyceride-rich lipoproteins (TGRL). Overexpression of human LR11 in CHO cells resulted in increased binding and association of 12I-labeled TGRL, but not of 12I-labeled LDL.
CONCLUSION:
Our data strongly suggest an involvement of LR11 in mediating the harmful effects of a high-fat diet on CVD progression. Elevated sLR11 levels may increase the CVD risk especially in subjects with delayed clearance of triglyceride-rich remnants, such as in FH patients.
AuthorsRanitha Vongpromek, Hideaki Bujo, Menno Hoekstra, Wolfgang J Schneider, Leonie van der Zee, Arend F L Schinkel, Suzanne J A Korporaal, Willem A Dik, Hiroyuki Ebinuma, Meizi Jiang, Adrie J M Verhoeven, Eric J G Sijbrands, Monique T Mulder
JournalAtherosclerosis (Atherosclerosis) Vol. 243 Issue 2 Pg. 429-37 (Dec 2015) ISSN: 1879-1484 [Electronic] Ireland
PMID26520897 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Apolipoproteins E
  • Biomarkers
  • Chylomicron Remnants
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • LDL-Receptor Related Proteins
  • LDLR protein, human
  • Lipoproteins
  • Membrane Transport Proteins
  • Receptors, LDL
  • SORL1 protein, human
  • Sorl1 protein, mouse
  • Triglycerides
Topics
  • Animals
  • Apolipoproteins E (deficiency, genetics)
  • Biomarkers (blood)
  • CHO Cells
  • Carotid Artery Diseases (blood, diagnosis, etiology, prevention & control)
  • Carotid Intima-Media Thickness
  • Chylomicron Remnants (blood)
  • Cricetulus
  • Diet, High-Fat
  • Disease Models, Animal
  • Hep G2 Cells
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
  • Hyperlipoproteinemia Type II (blood, complications, diagnosis, drug therapy, genetics)
  • LDL-Receptor Related Proteins (blood, genetics)
  • Lipoproteins (blood)
  • Male
  • Membrane Transport Proteins (blood, genetics)
  • Mice, Inbred C57BL
  • Mice, Knockout
  • RNA Interference
  • Receptors, LDL (blood, genetics, metabolism)
  • Risk Factors
  • Time Factors
  • Transfection
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: